Nordwest Clinic (Krankenhaus)
Nordwest Clinic (Krankenhaus)
Germany, Frankfurt am Main
Elke Jaeger
41 years of experience
Clinic is certified :
Immunotherapy for breast cancer in Germany typically costs from $22,000 to $38,000. Total costs depend on the drug mechanism, treatment duration, and diagnostic complexity. Patients save approximately 57% compared to the US, where average prices reach $70,000. Standard care includes drug administration, oncologist consultations, and specialized nursing in major hubs like Hamburg, Frankfurt, and Berlin.
Bookimed Expert Insight: Germany leads in personalized oncology through research-driven centers like Nordwest Clinic. Professor Elke Jaeger pioneered individual antitumor vaccines there. Choosing a Focus-ranked hospital ensures access to high-volume experts. For instance, Asklepios Hospital Barmbek treats every fourth breast cancer patient in Hamburg. This level of specialization often translates to more precise drug dosing. Higher initial costs for molecular diagnostics can actually save money long-term. This ensures patients only pay for therapies proven effective for their specific genetic markers.
Why choose Germany for immunotherapy for breast cancer?
Access advanced Immunotherapy for breast cancer solutions in trusted clinics .
| Germany | Turkey | Austria | |
| Immunotherapy for breast cancer | from $22,000 | from $9,500 | from $35,000 |
Day 1 - Arrival
Day 2 - Pre-Operation
Day 3 - Immunotherapy
Day 4 - Post-Operation
Week 1 to Week 3 - Rehabilitation
Week 4 to Week 6 - Rehabilitation
Please note that each patient reacts differently to immunotherapy. Therefore, this guide might not perfectly correspond to your individual journey. Always consult with your medical team for personalized information.
What patients like:
What patients don't like:
At Bookimed.com, we provide information on Immunotherapy for breast cancer and medical services in Germany. As the leading global medical tourism platform, we have huge responsibility before our clients — both patients and medical centers. All the information provided on Bookimed.com is grounded in research, foresight, and expertise and meets high interest related to the product and follows:
We form our listings of clinics and doctors with strict regulations of our smart automatic ranking system. The system is based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services in Germany there.
Our experienced data scientist collects data daily, monitors and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results.
We collect the opinions of Bookimed clients only after getting medical experience with the clinic — so everyone on the platform can trust the facility they choose. We strive to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com you may find choice and convenience to find the best medical solutions from top medical services providers in Germany just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content at every clinic’s page to make sure of its trustworthiness.
Our blog and supportive pieces are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value. That"s why all the data presented on the platform is collected, edited, reviewed, and updated regularly by our patients, our partner clinics in Germany, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com regarding Immunotherapy for breast cancer, please feel free to contact us at marketing@bookimed.com.
Dr. Manuela Seifert leads the Breast Cancer Center in Solingen, specializing in breast-sparing surgeries and aesthetic reconstruction with over 26 years of experience of experience.
Specializes in immunotherapy for breast cancer with a focus on molecular diagnostics and targeted therapies at Medical Center in Solingen.
Dr. Séverine Iborra leads the gynecology department at Städtisches Klinikum Solingen, with a focus on oncological diagnostics and breast cancer treatment.
Prof. Elke Jaeger is one of Germany's top oncologists according to Focus rating, specializing in sarcoma and breast cancer immunotherapy at Nordwest Clinic.
Approval status depends on the specific drug and breast cancer subtype. Keytruda (pembrolizumab) is fully approved by the European Medicines Agency for metastatic or early-stage triple-negative cases. Advanced options like dendritic cell vaccines are legally available under special regulatory exemptions but lack central authorization.
Bookimed Expert Insight: While university hospitals like Charite Berlin provide global-standard care, specialist centers such as Nordwest Clinic offer a unique advantage by combining standard oncology with in-house research institutes. This allows patients to access personalized vaccines and innovative therapies that are legally available in Germany even before receiving full European Medicines Agency authorization.
Patient Consensus: Patients emphasize that immunotherapy is not a universal solution. Success depends strictly on tumor biomarkers, and German doctors often recommend clinical trials when standard-of-care indications are not met.
Germany offers advanced immunotherapy mainly for triple-negative breast cancer (TNBC) using immune checkpoint inhibitors like pembrolizumab and atezolizumab. Treatment centers utilize biomarker-guided testing and PD-L1 status to personalize protocols. Specialized clinics also provide individualized dendritic cell vaccines and innovative clinical trials.
Bookimed Expert Insight: While many search for immunotherapy, German protocols strictly limit immune checkpoint inhibitors to triple-negative cases. At Nordwest Clinic, Prof. Dr. Elke Jaeger focuses on anticancer vaccines, which can serve as a vital complementary option for patients who do not qualify for standard drug-based immunotherapy due to their tumor subtype.
Patient Consensus: Patients emphasize that securing a second opinion at a major German breast center is essential. They often find that initial fatal diagnoses are refined through Germany's rigorous molecular diagnostics and advanced monitoring.
Top German institutions for breast cancer immunotherapy include Nordwest Clinic, Charite Berlin, and Heidelberg University Hospital. These centers specialize in advanced protocols like checkpoint inhibitors and dendritic cell vaccines, overseen by multidisciplinary tumor boards within Focus-certified oncology departments and Newsweek-ranked facilities.
Bookimed Expert Insight: While university hospitals like Charite focus on standard checkpoint inhibitors, clinics like Nordwest bridge the gap between research and practice. Prof. Elke Jaeger at Nordwest has 35 years of experience specifically in immunology. This clinic operates 5 research institutes, meaning patients often access innovative systemic therapies faster than at purely academic centers.
Patient Consensus: Patients emphasize the importance of having the original pathology report reviewed by German experts. Many share that high-volume centers often correct stage 4 diagnoses to more treatable conditions after comprehensive molecular testing.
Immunotherapy is highly effective for Triple-Negative Breast Cancer (TNBC) patients showing PD-L1 protein expression. Leading German oncology centers, including Nordwest Clinic and Charité Berlin, use checkpoint inhibitors combined with chemotherapy to increase survival rates and achieve pathological complete response in early-stage cases.
Bookimed Expert Insight: German university hospitals like Charité Berlin integrate molecular research directly into clinical practice. Prof. Elke Jaeger at Nordwest Clinic utilizes five research institutes to personalize drug therapy. This high-volume academic environment provides access to specific targeted regimens often unavailable at standard clinics.
Patient Consensus: Patients emphasize that immunotherapy is not a universal fix. They stress the importance of early biomarker testing to confirm eligibility and manage unique side effects like inflammation.
Breast cancer immunotherapy side effects primarily occur when the immune system overactivates and attacks healthy tissues. Most patients experience manageable symptoms like fatigue, skin rashes, or flu-like feelings. However, serious immune-related adverse events involving the lungs, liver, or thyroid require immediate medical monitoring and intervention.
Bookimed Expert Insight: Data from leading German centers like Nordwest Clinic shows that immunotherapy is often paired with molecular diagnostics. This precision helps specialists like Prof. Elke Jaeger predict patient responses more accurately. In Germany, specialized Breast Cancer Centers certified by the German Cancer Society prioritize early detection of organ inflammation through weekly blood monitoring.
Patient Consensus: Many patients describe the fatigue as a persistent exhaustion rather than temporary tiredness. They emphasize that while some feel fine initially, immune side effects often emerge months after starting the regimen.
German university hospitals and certified cancer centers like Nordwest Clinic (Krankenhaus) and Charite Berlin offer advanced breast cancer immunotherapy. These facilities specialize in checkpoint inhibitors for triple-negative cases and personalized anticancer vaccines. Leading specialists like Prof. Dr. Elke Jaeger integrate these biological therapies into multimodal oncology programs.
Bookimed Expert Insight: German oncology centers exhibit a major experience gap. While many clinics offer general cancer care, Nordwest Clinic and Charite Berlin consistently rank as Top 10 clinics in Focus magazine. This status reflects their ability to offer advanced tumor profiling and vaccines that smaller municipal hospitals often lack.
Patient Consensus: Patients emphasize the importance of molecular profiling for accurate diagnosis. Many highlight that traveling to German certified centers often leads to revised treatment plans that favor more targeted, less invasive immunological approaches.